Diarrhea News and Research

Latest Diarrhea News and Research

Toronto quarantines passengers from Tel Aviv with flu symptoms

Passengers on an Air Canada flight from Tel Aviv were briefly quarantined on their arrival at Toronto airport because of a health scare.

10 Jan 2008

Contaminated milk responsible for three deaths and a miscarriage

The latest incident in the United States involving bacteria-contaminated milk has claimed the lives of three elderly men and caused at least one pregnant woman to miscarry since last June.

9 Jan 2008

Brain response differences found in way women with irritable bowel syndrome deal with pain

UCLA researchers found that women with IBS cannot effectively turn-off a pain modulation mechanism in the brain, which causes them to be more sensitive to abdominal pain, compared to women without IBS.

9 Jan 2008

How to reduce gas

Gassiness: It's embarrassing, bothersome and yes, smelly. Sometimes, changing diet can clear the air.

3 Jan 2008

Anthrax vaccine will add to America's arsenal against bioterrorism

A company, based in Rockville, Maryland in the USA, with the help of government funding, has used the human genome to develop a vaccine that may give protection from anthrax.

19 Dec 2007

Bosutinib safe, effective for chronic myelogenous leukemia

A new drug for chronic myelogenous leukemia works for patients who have developed resistance to frontline therapy and causes fewer side effects than other medications in its class, a research team led by scientists at The University of Texas M. D. Anderson Cancer Center reports at the 49th annual meeting of the American Society of Hematology.

12 Dec 2007

Mouthguards harbor large numbers of bacteria - can lead to disease

Fractured teeth, neck injuries and abrasions in the mouth, also known as sports-related dental injuries, are ever present among athletes.

10 Dec 2007

Bacteria in cows' milk may cause Crohn's disease

Scientists at the University of Liverpool have found how a bacterium, known to cause illness in cattle, may cause Crohn’s disease in humans.

10 Dec 2007

FDA concludes no increased risk of cardiac events for patients treated with omeprazole and Nexium

The US Food and Drug Administration (FDA) has issued its final assessment of two small, open, long-term, clinical studies in patients with gastro-esophageal reflux disease (GERD), comparing anti-reflux surgery with either omeprazole (SOPRAN study) or NEXIUM (LOTUS study) treatment.

10 Dec 2007

Study results from Zolinza (vorinostat) in combination with bortezomib for multiple myeloma trial

Results from two investigational Phase I trials of ZOLINZA (vorinostat) in combination with bortezomib provide preliminary anti-tumor activity in patients with relapsed and/or refractory multiple myeloma.

10 Dec 2007

Premature ejaculation drug Dapoxetine submitted for marketing in approval in Europe

Janssen-Cilag companies in Europe have submitted a Marketing Authorisation Application (MAA) for dapoxetine, a treatment for premature ejaculation (PE) in men 18-64 years of age.

10 Dec 2007

Denial of care for HIV+ detainees 'unacceptable,' says AHF

On the heels of the Human Rights Watch report descrying the treatment of HIV-positive immigrant detainees, AIDS Healthcare Foundation (AHF) has criticized the U.S. Department of Homeland Security (DHS) for its callous disregard for the health and well-being of people living with HIV/AIDS in its care.

10 Dec 2007

ACG offers updated clinical guidance for managing pregnant patients

Physician experts from the American College of Gastroenterology have released an updated educational monograph highlighting the unique clinical challenges of caring for women with chronic digestive disorders during pregnancy and managing GI complications relating to pregnancy.

10 Dec 2007

Ebola ravages Uganda as local doctor dies after treating victims

With the latest reports suggesting that as many as 25 people have now fallen victim to the deadly virus, the new and mysterious strain of Ebola has infected some of the medical workers who treated patients without the aid of latex gloves and respirator gowns.

9 Dec 2007

Approval of Diovan (valsartan) in U.S. for hypertension in children and adolescents

Diovan (valsartan), an angiotensin receptor blocker or ARB, has been approved following a priority review by the U.S. Food and Drug Administration (FDA) for the treatment of high blood pressure in children and adolescents ages six to 16.

4 Dec 2007

Merck Serono's Cyanokit approved in Europe

Merck Serono, a division of Merck KGaA, announced today that the European Commission has granted marketing authorization for its product Cyanokit (active substance: hydroxocobalamin) for the treatment of known or suspected cyanide poisoning in both adults and the pediatric population.

3 Dec 2007

Could stem cells be used to cure Crohn's Disease?

Scientists are investigating whether stem cells could be used to 're-boot' the immune system and provide a cure for Crohn's Disease.

29 Nov 2007

Health officials should consider mass vaccination in their efforts to control endemic cholera

A vaccine used to protect travelers from cholera, an infection characterized by diarrhea and severe dehydration, could also be used effectively among those living in cholera-prone (endemic) areas, according to a research study by Ira Longini and colleagues published in PLoS Medicine.

27 Nov 2007

Cholera can be controlled with oral vaccines

Endemic cholera, a potentially fatal diarrheal disease found in the world's most impoverished countries, could be effectively controlled by orally vaccinating half of the affected populations once every two years for only pennies per dose, according to new findings by an international team of researchers led by Ira M. Longini Jr., Ph.D., a biostatistician in the Vaccine and Infectious Disease Institute at Fred Hutchinson Cancer Research Center in Seattle. Longini and colleagues will report their findings online Nov. 27 in PLoS Medicine.

27 Nov 2007

GlaxoSmithKline obtains U.S. OTC marketing rights to MEVACOR (lovastatin) from Merck

GlaxoSmithKline, Philadelphia, PA, USA (GSK) and Merck & Co., Inc., Whitehouse Station, NJ, USA (Merck), announced today that they have entered into an agreement for over-the-counter (OTC) marketing rights for MEVACOR (lovastatin).

27 Nov 2007